These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10857417)

  • 21. Rhabdomyolysis due to bezafibrate in CAPD patients. A role for dihydropyridine drugs?
    Weissgarten J; Zaidenstein R; Fishman S; Dishi V; Michovitz-Koren M; Averbukh Z; Golik A
    Perit Dial Int; 1999; 19(2):180-2. PubMed ID: 10357195
    [No Abstract]   [Full Text] [Related]  

  • 22. [Gemfibrozil induced rhabdomyolysis in a patient with undiscovered hypothyroidism].
    Barquero-Romero J; Rodríguez Vázquez C; Arrobas Vacas I
    An Med Interna; 2006 Oct; 23(10):504-5. PubMed ID: 17205640
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute renal failure due to rhabdomyolysis in presence of concurrent ciprofibrate and ibuprofen treatment.
    Ramachandran S; Giles PD; Hartland A
    BMJ; 1997 May; 314(7094):1593. PubMed ID: 9186171
    [No Abstract]   [Full Text] [Related]  

  • 24. Antidepressant and statin interactions: a review and case report of simvastatin and nefazodone-induced rhabdomyolysis and transaminitis.
    Karnik NS; Maldonado JR
    Psychosomatics; 2005; 46(6):565-8. PubMed ID: 16288136
    [No Abstract]   [Full Text] [Related]  

  • 25. Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: A rare case report and literature review.
    Wang D; Wang Y
    Medicine (Baltimore); 2018 Apr; 97(14):e0318. PubMed ID: 29620657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of adverse events with fibrates.
    Alsheikh-Ali AA; Kuvin JT; Karas RH
    Am J Cardiol; 2004 Oct; 94(7):935-8. PubMed ID: 15464682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simvastatin-associated rhabdomyolysis demonstrated on bone scan.
    Rhodes CA; Balon HR
    Clin Nucl Med; 2002 Nov; 27(11):793-4. PubMed ID: 12394127
    [No Abstract]   [Full Text] [Related]  

  • 28. A 68-year old male presenting with rhabdomyolysis-associated acute kidney injury following concomitant use of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate and pravastatin/fenofibrate: a case report.
    Suttels V; Florence E; Leys J; Vekemans M; Van den Ende J; Vlieghe E; Kenyon C
    J Med Case Rep; 2015 Sep; 9():190. PubMed ID: 26347243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fixed-dose combination fenofibrate/pravastatin 160/40 mg versus simvastatin 20 mg monotherapy in adults with type 2 diabetes and mixed hyperlipidemia uncontrolled with simvastatin 20 mg: a double-blind, randomized comparative study.
    Farnier M; Steinmetz A; Retterstøl K; Császár A
    Clin Ther; 2011 Jan; 33(1):1-12. PubMed ID: 21397769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pravastatin and fenofibrate in combination (Pravafenix(®)) for the treatment of high-risk patients with mixed hyperlipidemia.
    Farnier M
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):565-75. PubMed ID: 22651832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe rhabdomyolysis during a hypersensitivity reaction to abacavir in a patient treated with ciprofibrate.
    Fontaine C; Guiard-Schmid JB; Slama L; Essid A; Lukiana T; Rondeau E; Pialoux G
    AIDS; 2005 Nov; 19(16):1927-8. PubMed ID: 16227807
    [No Abstract]   [Full Text] [Related]  

  • 32. Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations.
    Oldemeyer JB; Lund RJ; Koch M; Meares AJ; Dunlay R
    Cardiology; 2000; 94(2):127-8. PubMed ID: 11173785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fibrate and statine myopathy].
    Finsterer J
    Nervenarzt; 2003 Feb; 74(2):115-22. PubMed ID: 12596012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rhabdomyolysis induced by fenofibrate monotherapy].
    Archambeaud-Mouveroux F; Lopez S; Combes C; Lassandre S; Amaniou M; Teissier MP; Galinat S
    Rev Med Interne; 2006 Jul; 27(7):573-4. PubMed ID: 16716459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myopathy associated with lipid lowering therapy in patients with previously undiagnosed or undertreated hypothyroidism.
    Lang JE; Wang P; Glueck CJ
    Clin Chim Acta; 1996 Oct; 254(1):65-92. PubMed ID: 8894313
    [No Abstract]   [Full Text] [Related]  

  • 36. [Muscular toxicity of antilipemic agents revealed during the course of hypothyroidism].
    Prudhomme F; Jacotot B
    Presse Med; 2003 Jun; 32(22):1031-2. PubMed ID: 12894778
    [No Abstract]   [Full Text] [Related]  

  • 37. Statin-fibrate combination therapy.
    Shek A; Ferrill MJ
    Ann Pharmacother; 2001; 35(7-8):908-17. PubMed ID: 11485144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.
    Duntas L; Kolovou G
    Future Cardiol; 2011 Mar; 7(2):137-44. PubMed ID: 21453018
    [No Abstract]   [Full Text] [Related]  

  • 39. Rhabdomyolysis after concomitant use of cyclosporine and simvastatin in a patient transplanted for multiple myeloma.
    Tong J; Laport G; Lowsky R
    Bone Marrow Transplant; 2005 Oct; 36(8):739-40. PubMed ID: 16086041
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of combination therapy with niceritrol and pravastatin on hyperlipidaemia.
    Kinoshita M; Mikuni Y; Kudo M; Mori M; Horie E; Teramoto T; Matsushima T
    J Int Med Res; 2002; 30(3):271-81. PubMed ID: 12166344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.